Seoul National University began the investigation after Hwang acknowledged there were "fatal errors" in a May article in the journal Science claiming that he and other researchers cloned human embryos and created 11 stem cell lines that genetically matched certain patients.
Scientists hope to use such "therapeutic cloning" someday to create tissue for transplant into people with illnesses like diabetes and Parkinson's disease.